Mar 19, 2025 · The most common treatment for hemophilia is to have preventive infusions of clotting factor given several times per week. But new treatments are available.

Explore treatment options for hemophilia, VWD, and rare bleeding disorders, from factor replacement to gene therapy.

Dec 5, 2025 · The treatment landscape for hemophilia has evolved rapidly over the past decade, with the approval of several therapies with novel mechanisms of action. Extended half-life …

In the current review of literature, we present and critically analyze the pros and cons of all the major discoveries in the diagnosis and treatment of HA and HB, as well as identify key areas …

We would like to show you a description here but the site won’t allow us.

Jan 31, 2019 · The plasma half-life of the standard therapies for hemophilia requires frequent administration within prophylaxis regimens. These are typically given 3 times per week to …

Mar 28, 2025 · Today, the FDA approved a novel treatment for hemophilia A or B, with or without factor VIII or IX inhibitors (neutralizing antibodies).